{"id":942023,"date":"2026-03-04T10:44:27","date_gmt":"2026-03-04T15:44:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/"},"modified":"2026-03-04T10:44:27","modified_gmt":"2026-03-04T15:44:27","slug":"upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/","title":{"rendered":"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <strong>Picard Medical Investors With Significant Losses Are Encouraged To Contact Faruqi &amp; Faruqi, LLP Securities Litigation Partner <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kMYQxQk8leJIPl4J3EuO5414dLAc-hTyDnWMmpK0GA2v9opBpOAOVjmXs1r7r1ssdDyP4oXO9yus3eEveLktQGV_Tk9dvrxnt_Mgic8CTJzaloxLQ4PE23jB3JgGQ85ZX5IxJpgdZeYm1sx5YvOfFQ==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>James (Josh) Wilson<\/strong><br \/>\n        <\/a><br \/>\n        <strong>\u00a0To Discuss Their Legal Rights<\/strong>\n      <\/p>\n<p>\n        <strong>If you purchased or acquired securities in <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RAjS2tCgi76AA1rQjBI3htk7PNzSCGz_IOSHBX2yw-CvgemA82Jxj1MddZLyikVh-AVGefue3VLSiXXCrLzzcdjvk6iabN5Xld3FyS5tVy0=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>Picard Medical<\/strong><br \/>\n        <\/a><br \/>\n        <strong> between September 2, 2025 and October 31, 2025 <\/strong>and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner <strong>Josh Wilson directly <\/strong>at <strong>877-247-4292 <\/strong>or <strong>212-983-9330 (Ext. 1310)<\/strong>.<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=snO4OAdSW_ne0zGzQVHMW9BFBSJalFbL3lDpkUvZcoOEjJBlXCLQcv6HRbjMBZIwF18MWuRMECd0J4zstKWssGKE_bbm2yLNA33wOoqXWF6m4JlZlJLb3QgCf7s7NhS5vbKVdj9iUIkFApcHsijE7w==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>[You may also click here for additional information]<\/strong><br \/>\n        <\/a>\n      <\/p>\n<p align=\"center\">\n        \n      <\/p>\n<p>NEW YORK, March  04, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AyWXvZWXBdpM7pP-GtRHZbjBDYnIdqRxD6d_y-o8ETiHG3TpZQRnRJQdpgcoG_XL6HfjsquYFpUOSmBwhWzcvpml7f7faO_UfbRRthnwRUw=\" rel=\"nofollow\" target=\"_blank\">Faruqi &amp; Faruqi, LLP<\/a>, a leading national securities law firm, is investigating potential claims against Picard Medical, Inc. (\u201cPicard\u201d or the \u201cCompany\u201d) (NYSE: PMI) and reminds investors of the <strong>April 13, 2026 deadline<\/strong> to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.<\/p>\n<p>Faruqi &amp; Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ooV42jaZXMDk5SGzpMUxgxjyNPdmQLwA5bDDgI29AXqnRTBqlzrpaAEPWhaiEXDSWE_7CM9b8dJ0Aa4935KNfnUTxJI8BSY3XsMOFO5SrYo=\" rel=\"nofollow\" target=\"_blank\">www.faruqilaw.com<\/a>.<\/p>\n<p>As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and\/or misleading statements and\/or failing to disclose that: (1) that Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and\/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) that Picard\u2019s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.<\/p>\n<p>On October 24, 2025, Picard Medical, Inc. (NYSE: PMI) shares closed at $5.31, a steep decline from the prior trading session\u2019s close of $13.20 on October 23, 2025. This represents a drop of $7.89 per share, or approximately a 59.8% decrease in value in a single session, marking one of the most significant one-day declines since the company\u2019s recent IPO.<\/p>\n<p>The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.<\/p>\n<p>Faruqi &amp; Faruqi, LLP also encourages anyone with information regarding Picard Medical\u2019s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.<\/p>\n<p>To learn more about the <strong>Picard Medical<\/strong> class action, go to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ooV42jaZXMDk5SGzpMUxgzk5F9pepsMLIQ5VotADytdYnT7isKKCEeMiZkiJYUIZsUt3nSbhyKxbwuEgB5oz2juxc5022o_FXxawMCgELP8=\" rel=\"nofollow\" target=\"_blank\"><strong>www.faruqilaw.com\/PMI<\/strong><\/a> or <strong>call<\/strong> Faruqi &amp; Faruqi partner <strong>Josh Wilson directly <\/strong>at <strong>877-247-4292 <\/strong>or <strong>212-983-9330 (Ext. 1310)<\/strong>.<\/p>\n<p>Follow us for updates on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GChLH0VCMog7TZ7EhtBR9EDMZzZMWaRE_zSyzTkITXqaW3ADmv0pI6VtPNB1QpOQptjh97k7VZTCQsMKtOA4RmqqsZzGnDnvg_u-5nYYfqQhRekWtiCwQzOQEEOKId6-\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DV36OJ4k5MkBfXQ_63Na3b92RqhPuZlKDZgfi3IlffnnqZml9Qb_k_TY_xcbilyIzzvqQdXr4AOHlcec77bksA==\" rel=\"nofollow\" target=\"_blank\">X<\/a>, or on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8Jv_k8KubyDKHFBLlQseOcYIt0jmTqx8aykjLtUoD87fF0MXd1lQBWcTVGzjCmC9tsR-dfvu8ou9PQgshetNkD5OOYuJPge7Uz_xM5mlbgQ=\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>.<\/p>\n<p>Attorney Advertising. The law firm responsible for this advertisement is Faruqi &amp; Faruqi, LLP (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ooV42jaZXMDk5SGzpMUxg49hqXUiQ9gDeVfj1HinQM3oyWlbwRQ-RGvkhMW9EkghtFOEN0uKkAGr5meBYovHqujFKxuY6fxtb6a3jSOsho4=\" rel=\"nofollow\" target=\"_blank\">www.faruqilaw.com<\/a>). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.<\/p>\n<p>A photo accompanying this announcement is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fPeDCIP5zvpRAFhJ1oK-XRdTHcwVvVpOxdRjjCY7Wj4qi7MqTrbYCpByCdTdkiGZmmwha4IjeS_nyWALeebnWaAmjV35Z6piy7tjH-K21zZHmLn9Kiysx8nzkrALrLYquOgTpMIQmdVTiNTbY8d2iw5vy1C1FoH-CHtCUtJ7oTANjpGWHtLGOgaKYuDu852IRs8iK03DuFo5uekYwLRJ4lBc4vBFlXnmTOqrNjHTxBWpf04xswdtvy2_lM3p1H4RyfjcRA3YMLEE3y4jUFucTg==\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/7f60c456-51b6-4096-a862-d5d3beda6cc5<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGY1MTlhNTctNDcwNS00ZmM3LWI4NmItYzdmNTgxNmIxYzQ1LTEwMjkyMDktMjAyNi0wMy0wNC1lbg==\/tiny\/Faruqi-Faruqi-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Picard Medical Investors With Significant Losses Are Encouraged To Contact Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson \u00a0To Discuss Their Legal Rights If you purchased or acquired securities in Picard Medical between September 2, 2025 and October 31, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) &#8212; Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Picard Medical, Inc. (\u201cPicard\u201d or the \u201cCompany\u201d) (NYSE: PMI) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-942023","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Picard Medical Investors With Significant Losses Are Encouraged To Contact Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson \u00a0To Discuss Their Legal Rights If you purchased or acquired securities in Picard Medical between September 2, 2025 and October 31, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) &#8212; Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Picard Medical, Inc. (\u201cPicard\u201d or the \u201cCompany\u201d) (NYSE: PMI) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff &hellip; Continue reading &quot;UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-04T15:44:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline\",\"datePublished\":\"2026-03-04T15:44:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/\"},\"wordCount\":560,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/\",\"name\":\"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY=\",\"datePublished\":\"2026-03-04T15:44:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/","og_locale":"en_US","og_type":"article","og_title":"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline - Market Newsdesk","og_description":"Picard Medical Investors With Significant Losses Are Encouraged To Contact Faruqi &amp; Faruqi, LLP Securities Litigation Partner James (Josh) Wilson \u00a0To Discuss Their Legal Rights If you purchased or acquired securities in Picard Medical between September 2, 2025 and October 31, 2025 and would like to discuss your legal rights, call Faruqi &amp; Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) &#8212; Faruqi &amp; Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Picard Medical, Inc. (\u201cPicard\u201d or the \u201cCompany\u201d) (NYSE: PMI) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff &hellip; Continue reading \"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-04T15:44:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline","datePublished":"2026-03-04T15:44:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/"},"wordCount":560,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/","name":"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY=","datePublished":"2026-03-04T15:44:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NTM1NCM3NDY2MTkxIzIwMTc2MzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upcoming-deadline-picard-medical-inc-pmi-securities-fraud-class-action-april-13-2026-lead-plaintiff-deadline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"UPCOMING DEADLINE: Picard Medical, Inc. (PMI) Securities Fraud Class Action \u2013 April 13, 2026 Lead Plaintiff Deadline"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=942023"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942023\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=942023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=942023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=942023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}